SCP Vitalife Partners II LP, 10% Owner at Recro Pharma, Inc. (REPH), sold 36,462 shares at $9.44 ($338K) on 2017-12-28, disclosed to the SEC on 2018-01-02.
Open-market sale of $338k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.44 | 5,926 | $56K | 16.5% |
| 2 | $9.44 | 5,926 | $56K | 16.5% |
| 3 | $9.19 | 12,305 | $113K | 33.5% |
| 4 | $9.19 | 12,305 | $113K | 33.5% |
| Total | $9.27 avg | 36,462 | $338K | 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $42K | — | Filing → |
| REPH | SELL | 2018-01-04 | $689K | — | Filing → |
| REPH | SELL | 2017-12-28 | $206K | — | Filing → |